Rethinking the Organization of Demonstration Tracks: The VLDB 2025 Experience
ACM SIGMOD Record · 20.07.2026 · 55 (2) · 65-71
DOI: 10.1145/3829088.3829097 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACM SIGMOD Record, online erschienen am 21.07.2026. Verfasst von Sourav S Bhowmick und 1 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Demonstration tracks are a vital part of premier data management conferences, enabling researchers to showcase interactive systems. However, growing submission volumes and increasing competitiveness place significant strain on the traditional review structure managed by a small number of chairs. This report describes our experience redesigning the organization of the VLDB 2025 demonstration track to improve scalability and review quality. We introduced a distributed organizational model with associate editors (AEs) responsible for subsets of submissions, enabling better coordination and balanced workloads. A diverse program committee was formed to ensure broad expertise and perspectives. We also refined the review workflow by establishing clearer evaluation guidelines, redesigning the review form, deploying automated COI management, and revisiting best demonstration selection procedures. Feedback from AEs indicates that these changes improved review quality, fairness, and scalability.
Zitieren
APA
Bhowmick, S. S., & Bonnet, P. (2026). Rethinking the Organization of Demonstration Tracks: The VLDB 2025 Experience. ACM SIGMOD Record, 55(2), 65-71. https://doi.org/10.1145/3829088.3829097
Vancouver
Bhowmick SS, Bonnet P. Rethinking the Organization of Demonstration Tracks: The VLDB 2025 Experience. ACM SIGMOD Record. 2026;55(2):65-71. doi:10.1145/3829088.3829097
BibTeX
@article{Bhowmick2026,
author = {Bhowmick, Sourav S and Bonnet, Philippe},
title = {Rethinking the Organization of Demonstration Tracks: The VLDB 2025 Experience},
journal = {ACM SIGMOD Record},
year = {2026},
volume = {55},
number = {2},
pages = {65--71},
doi = {10.1145/3829088.3829097}
}
EUVIMED